Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Cancer Research
|
December 2, 2021
Augmenting Adoptive T-cell Immunotherapy by Targeting the PD-1/PD-L1 Axis
Junyun Lai, Paul A Beavis, Jasmine Li, et al.
Clinical & Translational Immunology
|
May 11, 2019
Switching on the green light for chimeric antigen receptor T-cell therapy
Sherly Mardiana, Junyun Lai, Imran Geoffrey House, et al.
Nature Reviews. Immunology
|
April 21, 2021
Cellular networks controlling T cell persistence in adoptive cell therapy
Jack D Chan, Junyun Lai, Clare Y Slaney, et al.
Cancers
|
March 6, 2021
Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model
Ling Wu, Joanna Brzostek, Shvetha Sankaran, et al.
Frontiers in Oncology
|
April 26, 2021
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma
Fenggang Yu, Nicholas L Syn, Yanan Lu, et al.
European Journal of Immunology
|
April 27, 2013
The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells
Ginevra Licandro, Hwei Ling Khor, Ottavio Beretta, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 4, 2025
Implantable drug delivery system improves tolerability of anti-CD40/anti-PD1 and chemotherapy in a murine model of breast cancer
Samantha J Wade, Elahe Minaei, Ashleigh Hope, et al.
Blood
|
June 25, 2016
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities
Junyun Lai, Wei Jian Tan, Chien Tei Too, et al.
Scientific Reports
|
November 19, 2013
Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies
Adrian Chong Nyi Sim, Chien Tei Too, Min Zin Oo, et al.
Cancer Immunology Research
|
July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic Cells
Paul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Cancer Research
|
December 2, 2021
Augmenting Adoptive T-cell Immunotherapy by Targeting the PD-1/PD-L1 Axis
Junyun Lai, Paul A Beavis, Jasmine Li, et al.
Clinical & Translational Immunology
|
May 11, 2019
Switching on the green light for chimeric antigen receptor T-cell therapy
Sherly Mardiana, Junyun Lai, Imran Geoffrey House, et al.
Nature Reviews. Immunology
|
April 21, 2021
Cellular networks controlling T cell persistence in adoptive cell therapy
Jack D Chan, Junyun Lai, Clare Y Slaney, et al.
Cancers
|
March 6, 2021
Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model
Ling Wu, Joanna Brzostek, Shvetha Sankaran, et al.
Frontiers in Oncology
|
April 26, 2021
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma
Fenggang Yu, Nicholas L Syn, Yanan Lu, et al.
European Journal of Immunology
|
April 27, 2013
The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells
Ginevra Licandro, Hwei Ling Khor, Ottavio Beretta, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 4, 2025
Implantable drug delivery system improves tolerability of anti-CD40/anti-PD1 and chemotherapy in a murine model of breast cancer
Samantha J Wade, Elahe Minaei, Ashleigh Hope, et al.
Blood
|
June 25, 2016
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities
Junyun Lai, Wei Jian Tan, Chien Tei Too, et al.
Scientific Reports
|
November 19, 2013
Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies
Adrian Chong Nyi Sim, Chien Tei Too, Min Zin Oo, et al.
Cancer Immunology Research
|
July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic Cells
Paul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Page
of 3